A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
{{output}}
Patients with unresectable biliary tract carcinomas (BTCs) have a poor prognosis with a median overall survival of fewer than 12 months following systemic chemotherapy. In recent years, the identification of distinct molecular alterations with corresponding ta... ...
